Fredholm B B, Lindgren E, Lindström K, Nordstedt C
Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Acta Physiol Scand. 1987 Dec;131(4):543-51. doi: 10.1111/j.1748-1716.1987.tb08274.x.
In the present study, using rat hippocampal slices, we have further examined the stimulatory effect of alpha 1-adrenoceptors on the accumulation of cyclic AMP, which is known to depend on calcium and adenosine. The addition of noradrenaline (NA) stimulated the accumulation of [3H]inositol phosphates in [3H]inositol-treated slices. This effect was shared by carbachol (10-100 mumol l-1) but not by the adenosine receptor agonist 2-chloroadenosine (100 mumol l-1). The stimulatory effect of the alpha-agonists (phenylephrine or NA + propranolol) on cyclic AMP was shared by a diacylglycerol derivative, sn-1-oleyl-2-acetyl glycerol (OAG), and by the tumour-promoting phorbol esters phorboldibutyrate (PDiBu) and tetradecanoyl phorbol acetate (TPA). PDiBu caused a translocation of protein kinase C from soluble to particulate fractions. The effects of PDiBu and alpha-adrenoceptor stimulation on cyclic AMP were not additive. Surprisingly, carbachol (1-1000 mumol l-1) did not stimulate cyclic AMP accumulation in rat hippocampal slices either in the presence or in the absence of an adenosine receptor agonist. The results are compatible with the opinion that alpha-adrenoceptor stimulating drugs enhance the formation of inositol phosphates and diacylglycerol, which synergistically activate protein kinase C, which in turn augments the stimulation of cyclic AMP formation. Thus, a neurotransmitter whose principal biological effect is to stimulate inositol phosphate formation can influence cyclic AMP formation by virtue of an interaction with the actions of the ubiquitous neuromodulator adenosine. The fact that the effect of the alpha-receptor stimulation was not mimicked by a muscarinic agonist could indicate that other factors besides activation of inositol phospholipid hydrolys are important for this receptor-receptor interaction.
在本研究中,我们使用大鼠海马切片进一步研究了α1 - 肾上腺素能受体对环磷酸腺苷(cAMP)积累的刺激作用,已知该过程依赖于钙和腺苷。加入去甲肾上腺素(NA)可刺激经[3H]肌醇处理的切片中[3H]肌醇磷酸的积累。卡巴胆碱(10 - 100 μmol l-1)也有此作用,但腺苷受体激动剂2 - 氯腺苷(100 μmol l-1)则无此作用。α - 激动剂(去氧肾上腺素或NA + 普萘洛尔)对cAMP的刺激作用可被二酰基甘油衍生物sn - 1 - 油酰基 - 2 - 乙酰甘油(OAG)以及促肿瘤佛波酯佛波醇二丁酸酯(PDiBu)和十四烷酰佛波醇乙酸酯(TPA)所模拟。PDiBu可导致蛋白激酶C从可溶性组分转位至颗粒性组分。PDiBu和α - 肾上腺素能受体刺激对cAMP的作用并非相加性的。令人惊讶的是,无论有无腺苷受体激动剂存在,卡巴胆碱(1 - 1000 μmol l-1)均未刺激大鼠海马切片中cAMP的积累。这些结果与以下观点相符:α - 肾上腺素能受体激动药物可增强肌醇磷酸和二酰基甘油的形成,二者协同激活蛋白激酶C,进而增强对cAMP形成的刺激。因此,一种主要生物学效应是刺激肌醇磷酸形成的神经递质可通过与普遍存在的神经调质腺苷的作用相互影响来影响cAMP的形成。α - 受体刺激的效应未被毒蕈碱激动剂模拟这一事实可能表明,除肌醇磷脂水解激活外,其他因素对于这种受体 - 受体相互作用也很重要。